# Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents

> **NCT01342601** · NA · COMPLETED · sponsor: **Bitop AG** · enrollment: 72 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis
- Seasonal Allergic Conjunctivitis

## Interventions

- **DEVICE:** ect4allergy Nasal Spray (ANS01) and Eye Drops (AAT01)
- **DEVICE:** Placebo products

## Key facts

- **NCT ID:** NCT01342601
- **Lead sponsor:** Bitop AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2011-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342601, "Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01342601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*